ArticlePloS one2026
Inflammatory discordance phenotype in COPD: Dissociation between neutrophil-to-lymphocyte ratio and conventional markers.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) is a heterogeneous disorder with diverse inflammatory profiles. Long-term oxygen therapy (LTOT) identifies a subgroup of patients with advanced disease; however, the systemic inflammatory characteristics of this population remain incompletely defined.
objectiveTo investigate systemic inflammatory markers in clinically stable COPD patients according to LTOT status and to examine whether elevated NLR reflects conventional inflammatory activation or a distinct immune profile.
methodsThis study represents a secondary, exploratory subgroup analysis of a prospectively collected COPD cohort. Patients were stratified according to LTOT status and compared in terms of pulmonary function, gas exchange parameters, and inflammatory markers. NLR was analyzed in relation to total leukocyte count (WBC), C-reactive protein (CRP), eosinophil count, and oxygenation parameters. Between-group comparisons were performed using non-parametric tests, and correlation and multivariable regression analyses were conducted to identify independent associations with NLR.
resultsA total of 127 clinically stable COPD patients were included, of whom 31 (24.4%) were receiving LTOT. LTOT-treated patients had significantly higher NLR values compared with non-LTOT patients (6.32 ± 4.87 vs 3.68 ± 2.41, p = 0.001), accompanied by lower lymphocyte and eosinophil counts. In contrast, total leukocyte count and CRP levels were similar between groups. In multivariable analysis, WBC, eosinophil count, and CRP remained independently associated with NLR, whereas oxygenation parameters and pulmonary function measures were not.
conclusionsThis study suggests that NLR elevation in advanced COPD may not necessarily reflect overt systemic inflammation, but rather a distinct immune phenotype. Context-specific interpretation of NLR may therefore be required in advanced disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.